These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33721949)

  • 21. Controversial issues of neoadjuvant treatment in borderline resectable pancreatic cancer.
    Kang CM; Hwang HK; Choi SH; Lee WJ
    Surg Oncol; 2013 Jun; 22(2):123-31. PubMed ID: 23518243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients.
    Aoki S; Motoi F; Murakami Y; Sho M; Satoi S; Honda G; Uemura K; Okada KI; Matsumoto I; Nagai M; Yanagimoto H; Kurata M; Fukumoto T; Mizuma M; Yamaue H; Unno M;
    BMC Cancer; 2019 Mar; 19(1):252. PubMed ID: 30898101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perioperative Therapy for Borderline Resectable Pancreatic Cancer: What and When?
    Kim MP; Katz MHG
    Ann Surg Oncol; 2019 Jun; 26(6):1596-1597. PubMed ID: 30680479
    [No Abstract]   [Full Text] [Related]  

  • 24. Localized Pancreatic Cancer: Multidisciplinary Management.
    Coveler AL; Herman JM; Simeone DM; Chiorean EG
    Am Soc Clin Oncol Educ Book; 2016; 35():e217-26. PubMed ID: 27249726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility and safety of distal pancreatectomy with en bloc celiac axis resection (DP-CAR) combined with neoadjuvant therapy for borderline resectable and unresectable pancreatic body/tail cancer.
    Yoshitomi H; Sakai N; Kagawa S; Takano S; Ueda A; Kato A; Furukawa K; Takayashiki T; Kuboki S; Miyzaki M; Ohtsuka M
    Langenbecks Arch Surg; 2019 Jun; 404(4):451-458. PubMed ID: 30868241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New developments in the management of borderline resectable pancreatic cancer.
    Sharma J; Ng J; Goodman MD; Saif MW
    JOP; 2013 Mar; 14(2):123-5. PubMed ID: 23474551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant chemo(radio)therapy in upfront resectable pancreatic cancer - can we stratify patients better in the future?
    Andersson R; Tingstedt B
    Scand J Gastroenterol; 2023 Jan; 58(1):1-2. PubMed ID: 35856841
    [No Abstract]   [Full Text] [Related]  

  • 28. [Neoadjuvant therapy vs. upfront resection for resectable pancreatic cancer].
    Strobel O; Büchler MW
    Chirurg; 2017 Jul; 88(7):619. PubMed ID: 28573533
    [No Abstract]   [Full Text] [Related]  

  • 29. Neoadjuvant chemotherapy is associated with improved survival in patients with left-sided pancreatic adenocarcinoma.
    Ocuin LM; Hardacre JM; Ammori JB; Rothermel LD; Mohamed A; Selfridge JE; Bajor D; Winter JM
    J Surg Oncol; 2020 Dec; 122(8):1595-1603. PubMed ID: 32844445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Challenges and stratigies of neoadjuvant therapy for pancreatic cancer].
    Zhang TP; Luo WH; Qiu JD
    Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(10):704-707. PubMed ID: 33721947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modified Appleby Procedure for Pancreatic Adenocarcinoma: Does Improved Neoadjuvant Therapy Warrant Such an Aggressive Approach?
    Peters NA; Javed AA; Cameron JL; Makary MA; Hirose K; Pawlik TM; He J; Wolfgang CL; Weiss MJ
    Ann Surg Oncol; 2016 Oct; 23(11):3757-3764. PubMed ID: 27328946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of neoadjuvant chemotherapy for resectable pancreatic carcinoma].
    Motoi F; Kawaguchi K; Aoki T; Kudo K; Yabuuchi S; Fukase K; Mizuma M; Sakata N; Otsutomo S; Morikawa T; Hayashi H; Nakagawa K; Okada T; Yoshida H; Naitoh T; Katayose Y; Egawa S; Unno M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1632-6. PubMed ID: 24393872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current controversies in the stage-specific multidisciplinary management of pancreatic cancer.
    Katz MH; Landry J; Kindler HL
    Am Soc Clin Oncol Educ Book; 2014; ():e157-64. PubMed ID: 24857097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A Successful Case of Locally Advanced Pancreatic Cancer Undergoing Curative Total Pancreatectomy after Chemotherapy].
    Terashima T; Kawamoto S; Maekawa K; Shinozaki N; Kuroki N
    Gan To Kagaku Ryoho; 2020 Apr; 47(4):688-690. PubMed ID: 32389985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hope and frustration of neoadjuvant chemotherapy for resectable pancreatic cancer].
    Lu C; Miao Y; Gao WT
    Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):813-816. PubMed ID: 30392300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primarily resectable pancreatic adenocarcinoma - to operate or to refer the patient to an oncologist?
    Piątek M; Kuśnierz K; Bieńkowski M; Pęksa R; Kowalczyk M; Nawrocki S
    Crit Rev Oncol Hematol; 2019 Mar; 135():95-102. PubMed ID: 30819452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma.
    Abbott DE; Tzeng CW; Merkow RP; Cantor SB; Chang GJ; Katz MH; Bentrem DJ; Bilimoria KY; Crane CH; Varadhachary GR; Abbruzzese JL; Wolff RA; Lee JE; Evans DB; Fleming JB
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S500-8. PubMed ID: 23397153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant or Neoadjuvant Therapy in the Treatment in Pancreatic Malignancies: Where Are We?
    Wolff RA
    Surg Clin North Am; 2018 Feb; 98(1):95-111. PubMed ID: 29191281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer.
    Roland CL; Yang AD; Katz MH; Chatterjee D; Wang H; Lin H; Vauthey JN; Pisters PW; Varadhachary GR; Wolff RA; Crane CH; Lee JE; Fleming JB
    Ann Surg Oncol; 2015 Apr; 22(4):1168-75. PubMed ID: 25352267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiological evaluation of response to neoadjuvant treatment in pancreatic cancer.
    Cassinotto C; Sa-Cunha A; Trillaud H
    Diagn Interv Imaging; 2016 Dec; 97(12):1225-1232. PubMed ID: 27692675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.